APLN and heart failure: Importantly, administration of [Pyr1]-Apelin-13 (Ape13), the predominant Apelin fragment detected in human plasma and heart (Maguire et al., 2009; Zhen et al., 2013), was found to exert beneficial effects in heart failure patients (Japp et al., 2010).